Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer

« Previous Next »Molecular Oncology
Volume 2, Issue 3 , Pages 250-260, October 2008

Jane Bayani
- Department of Applied Molecular Oncology, Ontario Cancer Institute, Princess Margaret Hospital, University Health Network, Toronto, Ontario, M5G 2M9, Canada
Miltiadis Paliouras
- Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5T 3L9, Canada
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, M5G 1L5, Canada
Chris Planque
- Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5T 3L9, Canada
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, M5G 1L5, Canada
Shannon J.C. Shan
- The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
Cassandra Graham
- Department of Applied Molecular Oncology, Ontario Cancer Institute, Princess Margaret Hospital, University Health Network, Toronto, Ontario, M5G 2M9, Canada
Jeremy A. Squire
- Department of Pathology and Molecular Medicine, Richardson Lab. Queens University, Kingston, Ontario K7L 3N6, Canada
Eleftherios P. Diamandis
- Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5T 3L9, Canada
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, M5G 1L5, Canada
- Corresponding author. Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto M5G 1X5, Ontario, Canada. Tel.: +1 416 586 8443; fax: +1 416 619 5521.